Cargando…

Determinants of Statin Initiation Among Adult Diabetic Patients in Bonga, Ethiopia

BACKGROUND: Diabetes mellitus (DM) is a chronic degenerative disease associated with a high risk of chronic complications and comorbidities. According t the World Health Organization, 16.7 million people worldwide die of cardiovascular diseases each year. AIM OF THE STUDY: The aim of this study is t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kebede zelalem, Bezie, Feyisa, Desalegn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737626/
https://www.ncbi.nlm.nih.gov/pubmed/33335410
http://dx.doi.org/10.2147/DMSO.S283993
_version_ 1783622974014750720
author Kebede zelalem, Bezie
Feyisa, Desalegn
author_facet Kebede zelalem, Bezie
Feyisa, Desalegn
author_sort Kebede zelalem, Bezie
collection PubMed
description BACKGROUND: Diabetes mellitus (DM) is a chronic degenerative disease associated with a high risk of chronic complications and comorbidities. According t the World Health Organization, 16.7 million people worldwide die of cardiovascular diseases each year. AIM OF THE STUDY: The aim of this study is to evaluate determinants of statin initiation among diabetic patients. METHODS: A hospital-based cross-sectional study was conducted to evaluate statin initiation and determinants in Gebre Tsadik Shewa General Hospital, Bonga, Ethiopia. This hospital covers a catchment population of about 1.4 million and offers diagnosis and treatment in outpatient and inpatient settings in different departments. Epi data 4.0.2.49 and STATA 14.2 were used for data entry and analysis. Before analysis, presence of co-linearity and model fitness were checked. Chi-square statistics were used to check adequacy of cells for binary logistic regression. Bivariate analysis was done and p <0.25 was included in a multivariate model. Finally p-value less than 0.05 was considered a significant predictor. RESULTS: A total of 120 patients were included in this study, of which 77 (64.17%) were males. The mean age and standard deviation was 47.04 ± 12.13 years with 75% of patients ≥40 years. The mean duration of illness was 10.26 ± 0.6 years. Ninety-eight (81.67%) patients had varying comorbidities. Sixty-four (53.33%) patients developed complications. The majority of patients were evaluated by a general practitioner (GP). Fifty-one (42.5%) patients started statins. Of them, 31 (60.78%) started for secondary prevention. The majority of patients had atorvastatin with moderate dosage. Government insurance (p=0.029), polypharmacy (0.008), physician level of training (0.023) and previous counseling of patients about the importance of statins (p<001) were significantly associated with initiation of statins. CONCLUSION: Only near to 40% of patients started statins. Physician reluctance and unavailability of drugs were the most common reasons not to initiate statins. The hospital tries to provide medication. Physicians should evaluate patients in need of cardio-protective drugs.
format Online
Article
Text
id pubmed-7737626
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-77376262020-12-16 Determinants of Statin Initiation Among Adult Diabetic Patients in Bonga, Ethiopia Kebede zelalem, Bezie Feyisa, Desalegn Diabetes Metab Syndr Obes Original Research BACKGROUND: Diabetes mellitus (DM) is a chronic degenerative disease associated with a high risk of chronic complications and comorbidities. According t the World Health Organization, 16.7 million people worldwide die of cardiovascular diseases each year. AIM OF THE STUDY: The aim of this study is to evaluate determinants of statin initiation among diabetic patients. METHODS: A hospital-based cross-sectional study was conducted to evaluate statin initiation and determinants in Gebre Tsadik Shewa General Hospital, Bonga, Ethiopia. This hospital covers a catchment population of about 1.4 million and offers diagnosis and treatment in outpatient and inpatient settings in different departments. Epi data 4.0.2.49 and STATA 14.2 were used for data entry and analysis. Before analysis, presence of co-linearity and model fitness were checked. Chi-square statistics were used to check adequacy of cells for binary logistic regression. Bivariate analysis was done and p <0.25 was included in a multivariate model. Finally p-value less than 0.05 was considered a significant predictor. RESULTS: A total of 120 patients were included in this study, of which 77 (64.17%) were males. The mean age and standard deviation was 47.04 ± 12.13 years with 75% of patients ≥40 years. The mean duration of illness was 10.26 ± 0.6 years. Ninety-eight (81.67%) patients had varying comorbidities. Sixty-four (53.33%) patients developed complications. The majority of patients were evaluated by a general practitioner (GP). Fifty-one (42.5%) patients started statins. Of them, 31 (60.78%) started for secondary prevention. The majority of patients had atorvastatin with moderate dosage. Government insurance (p=0.029), polypharmacy (0.008), physician level of training (0.023) and previous counseling of patients about the importance of statins (p<001) were significantly associated with initiation of statins. CONCLUSION: Only near to 40% of patients started statins. Physician reluctance and unavailability of drugs were the most common reasons not to initiate statins. The hospital tries to provide medication. Physicians should evaluate patients in need of cardio-protective drugs. Dove 2020-12-08 /pmc/articles/PMC7737626/ /pubmed/33335410 http://dx.doi.org/10.2147/DMSO.S283993 Text en © 2020 Kebede zelalem and Feyisa. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Kebede zelalem, Bezie
Feyisa, Desalegn
Determinants of Statin Initiation Among Adult Diabetic Patients in Bonga, Ethiopia
title Determinants of Statin Initiation Among Adult Diabetic Patients in Bonga, Ethiopia
title_full Determinants of Statin Initiation Among Adult Diabetic Patients in Bonga, Ethiopia
title_fullStr Determinants of Statin Initiation Among Adult Diabetic Patients in Bonga, Ethiopia
title_full_unstemmed Determinants of Statin Initiation Among Adult Diabetic Patients in Bonga, Ethiopia
title_short Determinants of Statin Initiation Among Adult Diabetic Patients in Bonga, Ethiopia
title_sort determinants of statin initiation among adult diabetic patients in bonga, ethiopia
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737626/
https://www.ncbi.nlm.nih.gov/pubmed/33335410
http://dx.doi.org/10.2147/DMSO.S283993
work_keys_str_mv AT kebedezelalembezie determinantsofstatininitiationamongadultdiabeticpatientsinbongaethiopia
AT feyisadesalegn determinantsofstatininitiationamongadultdiabeticpatientsinbongaethiopia